1608125-68-3

Basic information

• Product Name: 3-methyl-1-((3-methyl-1-phenyl-1H-pyrazol-5-yl)methyl)-1H-pyrazol-5-ol
• Synonyms: 3-methyl-1-((3-methyl-1-phenyl-1H-pyrazol-5-yl)methyl)-1H-pyrazol-5-ol
• CAS NO: 1608125-68-3
• Molecular Weight: 268.318
• Mol File: 1608125-68-3.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 3-methyl-1-((3-methyl-1-phenyl-1H-pyrazol-5-yl)methyl)-1H-pyrazol-5-ol(CAS DataBase Reference)
• NIST Chemistry Reference: 3-methyl-1-((3-methyl-1-phenyl-1H-pyrazol-5-yl)methyl)-1H-pyrazol-5-ol(1608125-68-3)
• EPA Substance Registry System: 3-methyl-1-((3-methyl-1-phenyl-1H-pyrazol-5-yl)methyl)-1H-pyrazol-5-ol(1608125-68-3)

Safety Data

• Hazardous Substances Data: 1608125-68-3(Hazardous Substances Data)

Upstream product

• 1608125-48-9 (3-methyl-1-phenyl-1H-pyrazol-5-yl)methyl methanesulfonate 
• 132712-71-1 5-hydroxy-3-methylpyrazole 
• 81153-63-1 5-methyl-2-phenyl-pyrazole-3-carboxylic acid ethyl ester 
• 135351-18-7 (E)-1,1,1-trichloro-4-methoxypent-3-en-2-one 

Relevant articles and documents

PYRAZOLE DERIVATIVES AND THEIR USES THEREOF

The present disclosure relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof; wherein U, R1, R2, R3 and Q are as defined herein. The disclosure also provides a method for treating or preventing a method for the prevention, treatment and/or alleviation of one or more autoimmune or alloimmune disease, pharmaceutical compositions and combination comprising a therapeutically effective amount of a compound, as defined herein.